You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Pliva Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for PLIVA, and what generic and branded alternatives to PLIVA drugs are available?

PLIVA has seventy-six approved drugs.

There are six tentative approvals on PLIVA drugs.

Summary for Pliva
US Patents:0
Tradenames:46
Ingredients:44
NDAs:76
Drug Master File Entries: 1

Drugs and US Patents for Pliva

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pliva Hrvatska Doo ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 077112-002 Jun 25, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up
Pliva Lachema CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 078631-001 Dec 2, 2008 DISCN No No ⤷  Sign Up ⤷  Sign Up
Pliva Hrvatska Doo VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 078517-005 Jun 13, 2008 DISCN No No ⤷  Sign Up ⤷  Sign Up
Pliva Hrvatska Doo TOPIRAMATE topiramate TABLET;ORAL 077905-003 Mar 30, 2009 DISCN No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.